Skip to main content
Top
Published in: International Journal of Diabetes in Developing Countries 4/2019

01-10-2019 | Diabetic Foot | Original Article

Effects of diabetic foot infection on vascular and immune function in the lower limbs

Authors: Xiaohua Shen, Meixiang Zhang, Xuehua Jiao, Xiaofeng Cang, Ye Lu

Published in: International Journal of Diabetes in Developing Countries | Issue 4/2019

Login to get access

Abstract

Object

The study investigated the effects of diabetic foot infection on vascular and immune function in the lower limbs.

Methods

Seventy-two patients with diabetic foot infection were included in the infected group, while 64 diabetic patients without infection were selected as the control group. Hemodynamic parameters and vascular endothelial function of the dorsalis pedis artery were assessed by color Doppler ultrasonography. Enzyme-linked immunosorbent assay was used to determine the serum levels of interleukin 6 (IL-6), IL-17, tumor necrosis factor-α (TNF-α), C-reactive protein (CRP), and high mobility group box 1 protein (HMGB1). Western blotting was used to quantify expression levels of toll-like receptor 4 (TLR4) and nuclear transcription factor kappa B (NFκB) in human peripheral blood mononuclear cells (PBMC).

Results

Compared with the control group, the intima-media thickness and peak systolic velocity of the infected group were increased (both p < 0.05), while the inner vascular diameter, blood flow volume, endothelium-dependent dilation, and endothelium-independent dilation were decreased (all p < 0.05). Compared with the control group, the serum levels of IL-6, IL-17, TNF-α, CRP, and HMGB1, and the expression levels of TLR4 and NFκB in PBMC were significantly increased in the infected group (all p < 0.001).

Conclusion

Thus, diabetic foot infection is associated with vascular and immune dysfunction in the lower limbs, possibly in relation to the activation of the HMGB1/TLR4/NFκB signaling pathway.
Literature
1.
go back to reference d’Emden MC, Shaw JE, Jones GR, Cheung NW. Guidance concerning the use of glycated haemoglobin (HbA1c) for the diagnosis of diabetes mellitus. Med J Aust. 2015;203(2):89–90.PubMedCrossRef d’Emden MC, Shaw JE, Jones GR, Cheung NW. Guidance concerning the use of glycated haemoglobin (HbA1c) for the diagnosis of diabetes mellitus. Med J Aust. 2015;203(2):89–90.PubMedCrossRef
2.
go back to reference Kulprachakarn K, Ounjaijean S, Wungrath J, Mani R, Rerkasem K. Micronutrients and natural compounds status and their effects on wound healing in the diabetic foot ulcer. Int J Low Extrem Wounds. 2017;16(4):244–50.PubMedCrossRef Kulprachakarn K, Ounjaijean S, Wungrath J, Mani R, Rerkasem K. Micronutrients and natural compounds status and their effects on wound healing in the diabetic foot ulcer. Int J Low Extrem Wounds. 2017;16(4):244–50.PubMedCrossRef
3.
go back to reference Thurber EG, Kisuule F, Humbyrd C, Townsend J. Inpatient management of diabetic foot infections: a review of the guidelines for hospitalists. J Hosp Med. 2017;12(12):994–1000.PubMedCrossRef Thurber EG, Kisuule F, Humbyrd C, Townsend J. Inpatient management of diabetic foot infections: a review of the guidelines for hospitalists. J Hosp Med. 2017;12(12):994–1000.PubMedCrossRef
4.
go back to reference Zhao WN, Xu SQ, Liang JF, Peng L, Liu HL, Wang Z, et al. Endothelial progenitor cells from human fetal aorta cure diabetic foot in a rat model. Metabolism. 2016;65(12):1755–67.PubMedCrossRef Zhao WN, Xu SQ, Liang JF, Peng L, Liu HL, Wang Z, et al. Endothelial progenitor cells from human fetal aorta cure diabetic foot in a rat model. Metabolism. 2016;65(12):1755–67.PubMedCrossRef
5.
go back to reference Jhamb S, Vangaveti VN, Malabu UH. Genetic and molecular basis of diabetic foot ulcers: clinical review. J Tissue Viability. 2016;25(4):229–36.PubMedCrossRef Jhamb S, Vangaveti VN, Malabu UH. Genetic and molecular basis of diabetic foot ulcers: clinical review. J Tissue Viability. 2016;25(4):229–36.PubMedCrossRef
6.
go back to reference Lipsky BA, Silverman MH, Joseph WS. A proposed new classification of skin and soft tissue infections modeled on the subset of diabetic foot infection. Open Forum Infect Dis. 2017;4(1):ofw255. Lipsky BA, Silverman MH, Joseph WS. A proposed new classification of skin and soft tissue infections modeled on the subset of diabetic foot infection. Open Forum Infect Dis. 2017;4(1):ofw255.
7.
go back to reference Chen SY, Giurini JM, Karchmer AW. Invasive systemic infection after hospital treatment for diabetic foot ulcer: risk of occurrence and effect on survival. Clin Infect Dis. 2017;64(3):326–34.PubMedCrossRef Chen SY, Giurini JM, Karchmer AW. Invasive systemic infection after hospital treatment for diabetic foot ulcer: risk of occurrence and effect on survival. Clin Infect Dis. 2017;64(3):326–34.PubMedCrossRef
8.
go back to reference Hafez YM, El-Deeb OS, Atef MM. The emerging role of the epigenetic enzyme Sirtuin-1 and high mobility group Box 1 in patients with diabetic foot ulceration. Diabetes Metab Syndr. 2018;12(6):1065–70.PubMedCrossRef Hafez YM, El-Deeb OS, Atef MM. The emerging role of the epigenetic enzyme Sirtuin-1 and high mobility group Box 1 in patients with diabetic foot ulceration. Diabetes Metab Syndr. 2018;12(6):1065–70.PubMedCrossRef
9.
go back to reference Sun J, Shi S, Wang Q, Yu K, Wang R. Continuous hemodiafiltration therapy reduces damage of multi-organs by ameliorating of HMGB1/TLR4/NFκB in a dog sepsis model. Int J Clin Exp Pathol. 2015;8(2):1555–64.PubMedPubMedCentral Sun J, Shi S, Wang Q, Yu K, Wang R. Continuous hemodiafiltration therapy reduces damage of multi-organs by ameliorating of HMGB1/TLR4/NFκB in a dog sepsis model. Int J Clin Exp Pathol. 2015;8(2):1555–64.PubMedPubMedCentral
10.
go back to reference Lipsky BA, Berendt AR, Cornia PB, Pile JC, Peters EJ, Armstrong DG, et al. 2012 Infectious Diseases Society of America clinical practice guideline for the diagnosis and treatment of diabetic foot infections. J Am Podiatr Med Assoc. 2013;103(1):2–7.PubMedCrossRef Lipsky BA, Berendt AR, Cornia PB, Pile JC, Peters EJ, Armstrong DG, et al. 2012 Infectious Diseases Society of America clinical practice guideline for the diagnosis and treatment of diabetic foot infections. J Am Podiatr Med Assoc. 2013;103(1):2–7.PubMedCrossRef
11.
go back to reference Celermajer DS, Sorensen KE, Gooch VM. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosiz. Lancet. 1992;340(8828):1111–5.PubMedCrossRef Celermajer DS, Sorensen KE, Gooch VM. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosiz. Lancet. 1992;340(8828):1111–5.PubMedCrossRef
12.
go back to reference Guan D, Mi J, Chen X, Wu Y, Yao Y, Wang L, et al. Lung endothelial cell-targeted peptide-guided bFGF promotes the regeneration after radiation induced lung injury. Biomaterials. 2018;184:10–9.PubMedCrossRef Guan D, Mi J, Chen X, Wu Y, Yao Y, Wang L, et al. Lung endothelial cell-targeted peptide-guided bFGF promotes the regeneration after radiation induced lung injury. Biomaterials. 2018;184:10–9.PubMedCrossRef
13.
go back to reference Gao J, Zhao G, Li W, Zhang J, Che Y, Song M, et al. MiR-155 targets PTCH1 to mediate endothelial progenitor cell dysfunction caused by high glucose. Exp Cell Res. 2018;366(1):55–62.PubMedCrossRef Gao J, Zhao G, Li W, Zhang J, Che Y, Song M, et al. MiR-155 targets PTCH1 to mediate endothelial progenitor cell dysfunction caused by high glucose. Exp Cell Res. 2018;366(1):55–62.PubMedCrossRef
14.
go back to reference Li X, Xie X, Lian W, Shi R, Han S, Zhang H, et al. Exosomes from adipose-derived stem cells overexpressing Nrf2 accelerate cutaneous wound healing by promoting vascularization in a diabetic foot ulcer rat model. Exp Mol Med. 2018;50(4):29.PubMedPubMedCentralCrossRef Li X, Xie X, Lian W, Shi R, Han S, Zhang H, et al. Exosomes from adipose-derived stem cells overexpressing Nrf2 accelerate cutaneous wound healing by promoting vascularization in a diabetic foot ulcer rat model. Exp Mol Med. 2018;50(4):29.PubMedPubMedCentralCrossRef
15.
go back to reference You J, Sun J, Ma T, Yang Z, Wang X, Zhang Z, et al. Curcumin induces therapeutic angiogenesis in a diabetic mouse hindlimb ischemia model via modulating the function of endothelial progenitor cells. Stem Cell Res Ther. 2017;8(1):182.PubMedPubMedCentralCrossRef You J, Sun J, Ma T, Yang Z, Wang X, Zhang Z, et al. Curcumin induces therapeutic angiogenesis in a diabetic mouse hindlimb ischemia model via modulating the function of endothelial progenitor cells. Stem Cell Res Ther. 2017;8(1):182.PubMedPubMedCentralCrossRef
16.
go back to reference Xing Y, Lai J, Liu X, Zhang N, Ming J, Liu H, et al. Netrin-1 restores cell injury and impaired angiogenesis in vascular endothelial cells upon high glucose by PI3K/AKT-eNOS. J Mol Endocrinol. 2017;58(4):167–77.PubMedCrossRef Xing Y, Lai J, Liu X, Zhang N, Ming J, Liu H, et al. Netrin-1 restores cell injury and impaired angiogenesis in vascular endothelial cells upon high glucose by PI3K/AKT-eNOS. J Mol Endocrinol. 2017;58(4):167–77.PubMedCrossRef
17.
go back to reference Baluk P, Phillips K, Yao LC, Adams A, Nitschké M, McDonald DM. Neutrophil dependence of vascular remodeling after mycoplasma infection of mouse airways. Am J Pathol. 2014;184(6):1877–89.PubMedPubMedCentralCrossRef Baluk P, Phillips K, Yao LC, Adams A, Nitschké M, McDonald DM. Neutrophil dependence of vascular remodeling after mycoplasma infection of mouse airways. Am J Pathol. 2014;184(6):1877–89.PubMedPubMedCentralCrossRef
18.
go back to reference Almodovar S, Swanson J, Giavedoni LD, Kanthaswamy S, Long CS, Voelkel NF, et al. Lung vascular remodeling, cardiac hypertrophy, and inflammatory cytokines in SHIVnef-infected macaques. Viral Immunol. 2018;31(3):206–22.PubMedPubMedCentralCrossRef Almodovar S, Swanson J, Giavedoni LD, Kanthaswamy S, Long CS, Voelkel NF, et al. Lung vascular remodeling, cardiac hypertrophy, and inflammatory cytokines in SHIVnef-infected macaques. Viral Immunol. 2018;31(3):206–22.PubMedPubMedCentralCrossRef
19.
go back to reference Khanna S, Biswas S, Shang Y, Collard E, Azad A, Kauh C, et al. Macrophage dysfunction impairs resolution of inflammation in the wounds of diabetic mice. PLoS One. 2010;5:e9539.PubMedPubMedCentralCrossRef Khanna S, Biswas S, Shang Y, Collard E, Azad A, Kauh C, et al. Macrophage dysfunction impairs resolution of inflammation in the wounds of diabetic mice. PLoS One. 2010;5:e9539.PubMedPubMedCentralCrossRef
20.
go back to reference Fu Y, Lei J, Zhuang Y, Zhang K, Lu D. Overexpression of HMGB1 A-box reduced IL-1β-induced MMP expression and the production of inflammatory mediators in human chondrocytes. Exp Cell Res. 2016;349(1):184–90.PubMedCrossRef Fu Y, Lei J, Zhuang Y, Zhang K, Lu D. Overexpression of HMGB1 A-box reduced IL-1β-induced MMP expression and the production of inflammatory mediators in human chondrocytes. Exp Cell Res. 2016;349(1):184–90.PubMedCrossRef
21.
go back to reference He L, Sun F, Wang Y, Zhu J, Fang J, Zhang S, et al. HMGB1 exacerbates bronchiolitis obliterans syndrome via RAGE/NF-κB/HPSE signaling to enhance latent TGF-β release from ECM. Am J Transl Res. 2016;8(5):1971–84.PubMedPubMedCentral He L, Sun F, Wang Y, Zhu J, Fang J, Zhang S, et al. HMGB1 exacerbates bronchiolitis obliterans syndrome via RAGE/NF-κB/HPSE signaling to enhance latent TGF-β release from ECM. Am J Transl Res. 2016;8(5):1971–84.PubMedPubMedCentral
22.
go back to reference Rojas A, Delgado-López F, Perez-Castro R, Gonzalez I, Romero J, Rojas I, et al. HMGB1 enhances the protumoral activities of M2 macrophages by a RAGE-dependent mechanism. Tumour Biol. 2016;37(3):3321–9.PubMedCrossRef Rojas A, Delgado-López F, Perez-Castro R, Gonzalez I, Romero J, Rojas I, et al. HMGB1 enhances the protumoral activities of M2 macrophages by a RAGE-dependent mechanism. Tumour Biol. 2016;37(3):3321–9.PubMedCrossRef
23.
go back to reference Yan XX, Lu L, Peng WH, Wang LJ, Zhang Q, Zhang RY, et al. Increased serum HMGB1 level is associated with coronary artery disease in nondiabetic and type 2 diabetic patients. Atherosclerosis. 2009;205(2):544–8.PubMedCrossRef Yan XX, Lu L, Peng WH, Wang LJ, Zhang Q, Zhang RY, et al. Increased serum HMGB1 level is associated with coronary artery disease in nondiabetic and type 2 diabetic patients. Atherosclerosis. 2009;205(2):544–8.PubMedCrossRef
24.
go back to reference Yang J, Chen L, Ding J, Fan Z, Li S, Wu H, et al. MicroRNA-24 inhibits high glucose-induced vascular smooth muscle cell proliferation and migration by targeting HMGB1. Gene. 2016;586(2):268–73.PubMedCrossRef Yang J, Chen L, Ding J, Fan Z, Li S, Wu H, et al. MicroRNA-24 inhibits high glucose-induced vascular smooth muscle cell proliferation and migration by targeting HMGB1. Gene. 2016;586(2):268–73.PubMedCrossRef
25.
go back to reference Elfeky M, Kaede R, Okamatsu-Ogura Y, Kimura K. Adiponectin inhibits LPS-induced HMGB1 release through an AMP kinase and heme oxygenase-1-dependent pathway in RAW 264 macrophage cells. Mediat Inflamm. 2016;2016:1–9.CrossRef Elfeky M, Kaede R, Okamatsu-Ogura Y, Kimura K. Adiponectin inhibits LPS-induced HMGB1 release through an AMP kinase and heme oxygenase-1-dependent pathway in RAW 264 macrophage cells. Mediat Inflamm. 2016;2016:1–9.CrossRef
26.
go back to reference Meng L, Li L, Lu S, Li K, Su Z, Wang Y, et al. The protective effect of dexmedetomidine on LPS-induced acute lung injury through the HMGB1-mediated TLR4/NF-κB and PI3K/Akt/mTOR pathways. Mol Immunol. 2018;94:7–17.PubMedCrossRef Meng L, Li L, Lu S, Li K, Su Z, Wang Y, et al. The protective effect of dexmedetomidine on LPS-induced acute lung injury through the HMGB1-mediated TLR4/NF-κB and PI3K/Akt/mTOR pathways. Mol Immunol. 2018;94:7–17.PubMedCrossRef
Metadata
Title
Effects of diabetic foot infection on vascular and immune function in the lower limbs
Authors
Xiaohua Shen
Meixiang Zhang
Xuehua Jiao
Xiaofeng Cang
Ye Lu
Publication date
01-10-2019
Publisher
Springer India
Keyword
Diabetic Foot
Published in
International Journal of Diabetes in Developing Countries / Issue 4/2019
Print ISSN: 0973-3930
Electronic ISSN: 1998-3832
DOI
https://doi.org/10.1007/s13410-019-00750-1

Other articles of this Issue 4/2019

International Journal of Diabetes in Developing Countries 4/2019 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.